The Rate of Influenza Vaccination after Face-to-Face Interview in Pregnancy

Abstract

Purpose Most societies recommend routine influenza vaccine to all pregnant women. In Turkey, the Ministry of Health provides the influenza vaccine free of charge to pregnant women during the second and third trimesters. Pregnant women may not be willing to accept vaccination despite their knowledge and attitudes. We aimed to investigate the rate and determining factors of influenza vaccine acceptance after receipt of face-to-face information.

Methods Pregnant women were informed about the benefits of the influenza vaccine and asked if they would get the vaccine.

Results A total of 353 Turkish women were involved, and 191 (54.1%) accepted influenza vaccination. There was no statistically significant difference in terms of maternal age, body mass index, gravida, number of children, socioeconomic status, smoking and occupation between groups. Women in the third trimester had lower vaccination rates compared to first- and second-trimester pregnancies (35.7% vs. 67.7–64.2%). Women with at least a university degree also had lower vaccine uptake rates (58.1% vs. 59.5–36.8%). While 82.2% of women who accepted vaccination believed the benefit of the vaccine to the baby, the rate was 54.9% in the non-vaccinated group. The most common reason for refusal was the belief that influenza was not a serious disease. Vaccination uptake was higher especially for women who understood the benefits of the influenza vaccine for the baby (OR=3.79, 95%Cl=2.34–6.14).

Conclusion Women who had enough information, who had a lower education level, who had a previous history of influenza infection, and who had decided to have their babies vaccinated were more likely to accept influenza vaccine.

Keywords

Influenza A (H1N1) - vaccination - pregnancy - Turkey

Publication History

Received: 17 October 2020

Accepted after revision: 27 November 2020

Article published online:
18 January 2021

• References

• 1 Acs N, Bánhidy F, Puhó E. et al. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 2005; 73: 989-996
• 2 Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17: 3-10
• 3 Hartert TV, Neuzil KM, Shintani AK. et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003; 189: 1705-1712
• 4 Akdemir N, Ozdemir O, Koc F. Outcomes of oseltamivir treatment for H1N1 infection during pregnancy: a retrospective study. Gynecol Obstet Reprod Med 2011; 17: 4-6
• 5 Ozer A, Arikan DC, Kirecci E. et al. Status of pandemic influenza vaccination and factors affecting it in pregnant women in Kahramanmaras, an eastern Mediterranean city of Turkey. PLoS One 2010; 5: 14177
• 6 Tamma PD, Ault KA, del Rio C. et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009; 201: 547-552
• 7 Pasternak B, Svanström H, Mølgaard-Nielsen D. et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A (H1N1) vaccine during pregnancy. Jama 2012; 308: 165-174
• 8 ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy. Obstet Gynecol 2018; 131: 109-114
• 9 Yuen CYS, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women – a systematic review. Vaccine 2014; 32: 4602-4613
• 10 Maurici M, Dugo V, Zaratti L. et al. Knowledge and attitude of pregnant women toward flu vaccination: a cross-sectional survey. J Matern Fetal Neonatal Med 2016; 29: 3147-3150
• 11 TC Saglik Bakanligi, Turkish Public Health Instutition, Department of Women’s Reproductive Health). Doğum Öncesi Bakım Yönetim Rehberi (Antenatal Care Management Guideline) 2018
• 12 Fridman D, Steinberg E, Azhar E. et al. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol 2011; 204: 124-127
• 13 Henninger ML, Irving SA, Thompson M. et al. Factors associated with seasonal influenza vaccination in pregnant women. J Womens Health 2015; 24: 394-402
• 14 Fabry P, Gagneur A, Pasquier J-C. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine 2011; 29: 1824-1829
• 15 Tarrant M, Wu KM, Yuen CYS. et al. Determinants of 2009 A/H1N1 influenza vaccination among pregnant women in Hong Kong. Matern Child Health 2013; 17: 23-32
• 16 White SW, Petersen RW, Quinlivan JA. Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. Med J Aust 2010; 193: 405-407
• 17 Goldfarb I, Panda B, Wylie B. et al. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol 2011; 204: 112-115
• 18 Sakaguchi S, Weitzner B, Carey N. et al. Pregnant women’s perception of risk with use of the H1N1 vaccine. J Obstet Gynaecol Can 2011; 33: 460-467
• 19 Kay MK, Koelemay KG, Kwan-Gett TS. et al. 2009 pandemic influenza A vaccination of pregnant women—King County, Washington State, 2009–2010. Am J Public Health 2012; 368-374
• 20 Steelfisher GK, Blendon RJ, Bekheit MM. et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol 2011; 204: 116-123